“…Another study on ischemia/ reperfusion injury in neonate rat cardiomyocytes supports that cardiac D 1 receptors are not involved in cytoprotection, because selective activation of D 1 receptors with the agonist SKF-38393 (1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol) induces apoptotic cell death (Li et al, 2008). As NOD has been shown not to act on dopamine receptors (Lösel et al, 2010), our data clearly support that DA's cytoprotective action does not require dopamine receptor engagement (Brinkkoetter et al, 2006(Brinkkoetter et al, , 2008Benck et al, 2011). Direct evidence to underpin this assumption is provided by the data demonstrating that the protective effects of DA and NOD are not abrogated by the D 1 /D 2 receptor antagonist fluphenazine.…”